Statin as a Combined Therapy for Advanced-Stage Ovarian Cancer: A Propensity Score Matched Analysis

Table 2

Univariable and multivariable analysis: risk of mortality.

Characteristics	Univariable analysis	Multivariable analysis	HR (95% CI)
Age (≥65/<65 years)	0.535	0.734	1.176 (0.461–2.999)
FIGO stage (IV/III)	0.958	0.359	1.614 (0.581–4.485)
Tumor grade (G3/G1-2)	0.254	0.193	2.558 (0.622–10.513)
Histological subtype (Epithelial/nonepithelial)	0.653	0.752	1.250 (0.315–4.964)
Cytoreductive surgery (Residual tumor > 1/≤1 cm)	0.013	0.002	5.460 (1.894–15.742)
Statin (nonusage/usage)	0.966	0.255	1.764 (0.664–4.682)